Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now includes new navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and an updated Intervention/Treatment label, plus a Last Verified field and a Revision: v3.6.0 indicator, while older labels such as Verified, Last known status was:, Interventions / Treatment, and Revision: v3.5.5 were removed.SummaryDifference1%

- Check21 days agoChange DetectedThe page’s revision label changed from v3.5.4 to v3.5.5, indicating a newer edition of the ClinicalTrials.gov record. This appears to be a minor update to the page rather than a substantive change to study details.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3, indicating a small maintenance update to the page's revision history.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s display version rather than the underlying study record content.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check100 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 to reflect the latest site version.SummaryDifference0.0%

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.